PGNY:NASDAQProgyny, Inc. analysis
Data as of Oct 19, 2026 - not real-time
- Latest price
- $27.58
- Risk: medium
- 6/10Medium risk
Summary
Progyny, Inc. is priced at $27.58 and its moving averages line up in bullish order, the shorter sitting above the longer. Over a rolling month the price has gained 6.3%. With RSI at 55.9 the momentum picture is neutral, alongside a bullish MACD signal. The recent range runs from support at $24.33 up to resistance at $28.82.
The shares look fair, trading on 30.0 times earnings in line with a sector average of 31.3. The average analyst target implies 24.8% above today's level. Revenue is growing at 5.3% on a 6.0% profit margin.
The composite risk read is 6/10, putting it in elevated territory. With 30-day volatility of 32.7%, a beta of 0.34 and a maximum drawdown of 42.6%, position sizing matters here. The wider market backdrop reads extreme greed at 90 on the fear-greed composite.
All three time horizons resolve to buy, carrying 6/10 conviction.
The shares look fair, trading on 30.0 times earnings in line with a sector average of 31.3. The average analyst target implies 24.8% above today's level. Revenue is growing at 5.3% on a 6.0% profit margin.
The composite risk read is 6/10, putting it in elevated territory. With 30-day volatility of 32.7%, a beta of 0.34 and a maximum drawdown of 42.6%, position sizing matters here. The wider market backdrop reads extreme greed at 90 on the fear-greed composite.
All three time horizons resolve to buy, carrying 6/10 conviction.
Top market events
- Let’s dig into the relative performance of Progyny NASDAQ:PGNY and its peers as we unravel the now-completed Q2...
- Let’s dig into the relative performance of Progyny NASDAQ:PGNY and its peers as we unravel the now-completed Q2...
- Second-quarter revenue reached USD 350.51 million, up 5.30 percent year over year. Progyny stock was
Market outlook
Short term
< 1 yearPositive
Model confidence7/107 out of 10
Key factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 24.28
- MACD momentum is positive
Medium term
1–3 yearsPositive
Model confidence6/106 out of 10
Key factors
- Short-term moving averages stacked above long-term ones
- P/E of 30.0 versus sector average of 31.3
- Trading above the 200-day average of 24.28
Long term
> 3 yearsPositive
Model confidence6/106 out of 10
Key factors
- P/E of 30.0 versus sector average of 31.3
- Analyst targets imply +24.8% versus the current price
- Return on equity of 16.2%
Key metrics
Financial health
Revenue Growth5.30%
Profit Margin6.00%
P/E Ratio30.0
ROE16.24%
ROA10.14%
Debt/Equity5.95
P/B Ratio4.7
Op. Cash Flow$201.2M
Free Cash Flow$196.5M
Industry P/E31.3
Technical analysis
TrendBullish
RSI55.9
Support$24.33
Resistance$28.82
MA 20$26.46
MA 50$26.44
MA 200$24.28
MACDBullish
VolumeDecreasing
Fear & Greed Index89.88
Valuation
Fair Value$41.59
Target Price$34.42
Upside/Downside24.79%
GradeFair
TypeGrowth
Risk assessment
Beta0.34
Volatility32.74%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar tickers
9989
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H
stock603392
Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Class A
stock600989
Ningxia Baofeng Energy Group Co., Ltd. Class A
stockAVGO
Broadcom Inc.
stock600346
Hengli Petrochemical Co., Ltd. Class A
stock601985
China National Nuclear Power Co. Ltd. Class A
stockThis analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.